Heritage Wealth Advisors Neu Base Therapeutics, Inc. Transaction History

Heritage Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	BUY	$2.6 - $4.18 $2,600 - $4,180	1,000 Added 11.11%	10,000 $28,000
Q2 2021 Jul 27, 2021	BUY	$4.63 - $7.34 $18,520 - $29,360	4,000 Added 80.0%	9,000 $63,000
Q1 2021 Apr 27, 2021	SELL	$6.92 - $12.36 $27,680 - $49,440	-4,000 Reduced 44.44%	5,000 $36,000
Q4 2020 Feb 01, 2021	SELL	$6.92 - $9.25 $13,840 - $18,500	-2,000 Reduced 18.18%	9,000 $63,000
Q3 2020 Nov 03, 2020	SELL	$7.25 - $9.71 $13,775 - $18,449	-1,900 Reduced 14.73%	11,000 $83,000

Q2 2020 Jul 17, 2020	BUY	$6.69 - $11.51 $85,953 - $147,880	12,848 Added 24707.69%	12,900 $113,000
Q2 2020 Jul 17, 2020	SELL	$6.69 - $11.51 $80,601 - $138,672	-12,048 Reduced 99.57%	52 $113,000
Q4 2019 Feb 04, 2020	BUY	$4.5 - $8.1 $4,950 - $8,910	1,100 Added 10.0%	12,100 $87,000
Q3 2019 Oct 30, 2019	BUY	$3.15 - $6.59 $34,650 - $72,490	11,000 New	11,000 $54,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Advisors with notifications on news.